The report is titled as ‘Vulvodynia Treatment Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the vulvodynia treatment market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. Vulvodynia treatment market is expected to grow with significant rate in the near future.
The global vulvodynia treatment market in 2020 is estimated for more than US$ 4.9 Bn and expected to reach a value of US$ 7.7 Bn by 2028 with a significant CAGR of 5.9%.
Vulvodynia Treatment Market Definition
The vulvodynia treatment market is influenced by the prevailing skin disorders across the globe. Besides, the development of innovative and user-friendly products by the key players coupled with the increasing investments in dermatology creates growth opportunities for the market during the upcoming years. These innovative and advancedproducts aid the expansion of product portfolio that further helps in strengthening of their business growth globally.
Vulvodynia Treatment Market Dynamics
The growing occurrence of vulvodynia is the major growth driving factor for the vulvodynia treatment market. For instance, a study conducted by the University of Michigan stated that around 1 in 4 women are likely to experience vulvar pain during their lifetime. Besides, vulvar pain is responsible for both physical and mental stress.
Moreover, the incidence of a product in the pipeline coupled with the rise in demand for the anti-convulsant segment is also likely to affect the market growth during the forecast period. Other factors like the advancements in technology in healthcare facilities along with the diagnostic services also propel market growth. As per the study published in the American Journal of Obstetrics and Gynecology in 2019, revealed the facts that the sexual function in the females suffering from vulva pain is likely to improve with oral nerve pain medication named Gabapentin.
The onset of side effects linked with the treatment like hives, difficulty breathing, swelling of the face, lips, tongue, or throat, blurred vision, etc. and the low awareness about the disease and its treatment in emerging nations hamper the market growth.
Moreover, the physicians offering self-care services along with the treatments for vulvodynia offers a lucrative growth opportunity for the market. On the contrary, the inadequate knowledge of skilled professionals with vulvodynia treatment serves to be the major challenging affecting the growth of the vulvodynia treatment market.
Ipsen Pharma demonstrated a leadership position in neurotoxin research with a strong presence at TOXINS held in January 2019 and the study of US's National Vulvodynia Association to derive a conclusion that nearly 16% of total female population experiences this condition at some point. Such factors are also responsible for fueling the growth of the vulvodynia treatment market.
Vulvodynia Treatment Market Segmentation
The vulvodynia treatment market is segmented on the basis of drug class, mode of administration, distribution channel, and by region.
Key players operating in the global vulvodynia treatment market include Allergan plc., AstraZeneca Plc., Depomed Inc., Eli Lilly and Company, GlaxoSmithKline Plc., Janssen Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., National Vulvodynia Association, Noven Pharmaceuticals, Inc., Pfizer Inc., Sanofi Aventis, and Upsher-Smith Laboratories, LLC.
Regional Segmentation
On the basis of region, the vulvodynia treatment market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
MMC Overview on Vulvodynia Treatment Market Report
The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.
A research report on the Vulvodynia Treatment market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.
Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.
Factors that are benchmarked while estimating the market
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
• New product designs and launches
• Current product compliance
• Reimbursement
• Concerns for use of Vulvodynia Treatment
• Advantages of Vulvodynia Treatment
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.
1. Global Vulvodynia Treatment Market Report Overview
1.1. Introduction
1.2. Report Description
1.3. Methodology
2. Global Vulvodynia Treatment Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Executive Summary
2.3. Global Vulvodynia Treatment Market Snapshot
2.4. Global Vulvodynia Treatment Market Size and Forecast, 2020–2028
2.4.1. Introduction
2.4.2. Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)
2.5. Global Vulvodynia Treatment Market Dynamics
2.5.1. Drivers
2.5.2. Restraints
2.5.3. Opportunity
2.5.4. Trends
2.6. Key Regulations
2.7. Porter’s Five Forces Model
3. Global Vulvodynia Treatment Market, By Drug Class
3.1. Introduction
3.1.1. Annual Growth Rate Comparison, By Drug Class
3.1.2. BPS Analysis, By Drug Class
3.2. Market Revenue (US$Mn) Forecast, By Drug Class
12.4. Africa Vulvodynia Treatment Market, By Mode Of Administration
12.4.1. Oral
12.4.2. Topical
12.4.3. Injectable
12.5. Africa Vulvodynia Treatment Market, By Distribution Channel
12.5.1. Hospital Pharmacies
12.5.2. Retail Pharmacies
12.5.3. Drug Stores
12.5.4. Online Pharmacies
12.6. Africa Vulvodynia Treatment Market Attractiveness Index
12.6.1. By Country
12.6.2. By Distribution Channel
12.6.3. By Mode Of Administration
12.6.4. By Drug Class
13. Recommendation
13.1. Market Strategy
14. Competitive Landscape
14.1. Competition Dashboard
14.2. List and Company Overview of Global Key Players
14.3. Company Profiles
14.3.1. Allergan plc.
14.3.1.1. Company Overview
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. Key Developments
14.3.1.5. Business Strategies
14.3.2. AstraZeneca Plc.
14.3.3. Depomed Inc.
14.3.4. Eli Lilly and Company
14.3.5. GlaxoSmithKline Plc.
14.3.6. Janssen Pharmaceuticals, Inc.
14.3.7. Johnson & Johnson Services, Inc.
14.3.8. National Vulvodynia Association
14.3.9. Noven Pharmaceuticals, Inc.
14.3.10. Pfizer Inc.
14.3.11. Sanofi Aventis
14.3.12. Upsher-Smith Laboratories, LLC
15. Acronyms
Frequently Asked Questions
What is the projected market size & Compound Annual Growth Rate (CAGR) of the market?
The global vulvodynia treatment market in 2020 is estimated for more than US$ 4.9 Bn and expected to reach a value of US$ 7.7 Bn by 2028 with a significant CAGR of 5.9%.
What are the key factors driving the growth of market?
The growing occurrence of vulvodynia and the incidence of a product in the pipeline coupled with the rise in demand for the anti-convulsant segment are the key factors driving the growth of market
What segments are covered in market report?
The vulvodynia treatment market is segmented on the basis of drug class, mode of administration, distribution channel, and by region.
What are the key participating players in the market?
Key players operating in the global vulvodynia treatment market include Allergan plc., AstraZeneca Plc., Depomed Inc., Eli Lilly and Company, GlaxoSmithKline Plc., Janssen Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., National Vulvodynia Association, Noven Pharmaceuticals, Inc., Pfizer Inc., Sanofi Aventis, and Upsher-Smith Laboratories, LLC.
